NEW YORK (GenomeWeb News) – Luminex will be offering its molecular diagnostics directly to customers starting Jan. 1, 2013, the company said on Tuesday at its annual investor day conference.

The decision comes as Luminex's distribution deals with Abbott and Thermo Fisher Scientific expire at the end of this year and the Austin, Texas-based firm plans several new product launches in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.